US Patent 11883490 Induction of IL-12 using immunotherapy
Patent 11883490 was granted and assigned to Mirror Biologics, Inc. on January, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 1 Feb, 2024
Golden AI
Edits made to:
Infobox (+27 properties)
Article (+432 characters)
US Patent 11883490 Induction of IL-12 using immunotherapy
Article
Patent abstract
The present invention relates to compositions and methods that promote the induction of IL-12 in a patient. The composition includes activated allogeneic cells that are administered to a patient with a disease such as cancer. Administration of the composition skews the patient's immune response to a Th1 environment and produces detectable levels of IL-12 in the patient's plasma, without any IL-12 related toxicity.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Michael Har-Noy0
Date of Patent
January 30, 2024
0Patent Application Number
173260090
Date Filed
May 20, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11883490 Induction of IL-12 using immunotherapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
